CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
December 14, 2022 in Blog

The Importance of Risk Assessment as a Foundation of RBQM

Author: Rod Rahimi, Solution Expert at CluePoints. Risk assessment is the foundation of Risk Based Quality Management (RBQM). The adoption of statistics to assist with…
Read More
December 13, 2022 in News

CluePoints Appoints Andy Cooper as New Chief Executive Officer

New CEO brings a combination of experience and drive as CluePoints rapidlyscales its RBQM and Data Quality Oversight offerings King of Prussia, PA – December…
Read More
December 6, 2022 in Uncategorized

10 reasons people like working at CluePoints

From the friendly, supportive culture to making a difference in people’s lives, there are a million and one reasons why people love working at CluePoints.…
Read More
November 16, 2022 in Blog, Uncategorized

RBQM and ML: Perfect Partners for More Efficient Clinical Trials

Artificial intelligence (AI) and risk-based quality management (RBQM) are growing trends in pharma – and the two go together like strawberries and cream. For decades,…
Read More
October 11, 2022 in Uncategorized

Twin Peaks: 10 years of CluePoints and Risk-Based Monitoring

It’s been ten years since CluePoints set out on a journey to let clinical trial data speak for itself – and what a journey it…
Read More
October 11, 2022 in News, Uncategorized

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials

Risk-Based Quality Management: A front row seat to a decade of transformation King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions…
Read More
October 5, 2022 in Uncategorized

The Inaugural ACDM AI & ML Conference Promises to Move the Dial

CluePoints is excited to participate in a brand-new annual conference designed to help the research sector level up its artificial intelligence (AI) and machine learning…
Read More
September 12, 2022 in Uncategorized

Natural Language Processing Improves Risk Signal Documentation in Clinical Trials

Authors: Sylviane de Viron, Data and Knowledge Manager Nicolas Huet, Machine Learning Manager Central monitoring helps sponsors proactively identify quality issues in clinical trials. To…
Read More
September 6, 2022 in Blog, News

Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare

According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical…
Read More
August 30, 2022 in Blog, Uncategorized

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future

CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor King of Prussia, PA  – Aug 30th, 2022: Industry-leading risk-based study execution and data quality…
Read More


Find out where we’re headed next.

Featured Whitepaper

ICH E6 (R2)

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.


Platform Users


Studies De-Risked


Issues Detected